Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Leukaemia
Closed
Phase 2/3
This trial is looking at whether having obinutuzumab after chemotherapy reduces the risk of chronic lymphocytic leukaemia (CLL) coming back. The trial is supported by Cancer Research UK.
Recruitment start: 6 February 2015
Recruitment end: 25 February 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche Products Ltd
University of Leeds
This is Cancer Research UK trial number CRUK/11/040.
Last reviewed: 27 Feb 2017
CRUK internal database number: 1851
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
